Home / Conferences / CBI’s 13th Biosimilars Summit 2018

CBI’s 13th Biosimilars Summit 2018 Posted 17/11/2017

CBI’s 13th Biosimilars Summit
23−24 January 2018
Alexandria, VA, USA

CBI’s 13th annual Biosimilars Summit from 23−24 January 2018 in Alexandria, VA, USA is your first chance in 2018 to attend the leading event that continually stays on the pulse of the biosimilars’ ever-changing market and convenes key stakeholders including biosimilar and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing timely challenges and best practices for biosimilar product success.  Read the full agenda here! 

Join leaders from Merck and Life Science Connect to unpack 2017 biosimilars predictions and discuss potential implications in 2018, listen to the valuable perspectives from leaders at Glaxo Smith Kline and Independent Health as they dive into a payer perspective town hall---discussing practical insights to improve product uptake and encourage biosimilar adoption,and so much more. 

For information on team discounts, please contact Matt Douglas at +1 339 298 2144 or matthew.douglas@cbinet.com

Generics News Research General


Biosimilars News Research General